Pharmacology & ToxicologybioRxivPreprint
Targeting redox regulatory site of protein kinase B impedes neutrophilic inflammation
Po-Jen Chen, I-Ling Ko, Chia-Lin Lee…·Tsong-Long Hwang
This study identifies CLLV-1 as a covalent AKT inhibitor that targets Cys310 to reduce neutrophilic inflammation and acute lung injury.